|
|
||||||||
Cells from CD8+ T Cell-Mediated Autoimmune Destruction1





* St. Vincents Institute of Medical Research, Fitzroy, Victoria, Australia;
Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia;
Department of Microbiology and Infectious Diseases and Julia McFarlane Diabetes Research Center, University of Calgary, Alberta, Canada; and
Department of Microbiology and Immunology, University of Melbourne, Parkville, Victoria, Australia
In type 1 diabetes, cytokine action on
cells potentially contributes to
cell destruction by direct cytotoxicity, inducing Fas expression, and up-regulating class I MHC and chemokine expression to increase immune recognition. To simultaneously block
cell responsiveness to multiple cytokines, we overexpressed suppressor of cytokine signaling-1 (SOCS-1). This completely prevented progression to diabetes in CD8+ TCR transgenic nonobese diabetic (NOD) 8.3 mice without affecting pancreas infiltration and partially prevented diabetes in nontransgenic NOD mice. SOCS-1 appeared to protect at least in part by inhibiting TNF- and IFN-
-induced Fas expression on
cells. Fas expression was up-regulated on
cells in vivo in prediabetic NOD8.3 mice, and this was inhibited by SOCS-1. Additionally, IFN-
-induced class I MHC up-regulation and TNF- and IFN-
-induced IL-15 expression by
cells were inhibited by SOCS-1, which correlated with suppressed 8.3 T cell proliferation in vitro. Despite this, 8.3 T cell priming in vivo appeared unaffected. Therefore, blocking
cell responses to cytokines impairs recognition by CD8+ T cells and blocks multiple mechanisms of
cell destruction, but does not prevent T cell priming and recruitment to the islets. Our findings suggest that increasing SOCS-1 expression may be useful as a strategy to block CD8+ T cell-mediated type 1 diabetes as well as to more generally prevent cytokine-dependent tissue destruction in inflammatory diseases.
This article has been cited by other articles:
![]() |
X. Huang, D. J. Moore, R. J. Ketchum, C. S. Nunemaker, B. Kovatchev, A. L. McCall, and K. L. Brayman Resolving the Conundrum of Islet Transplantation by Linking Metabolic Dysregulation, Inflammation, and Immune Regulation Endocr. Rev., August 1, 2008; 29(5): 603 - 630. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Ronn, N. Billestrup, and T. Mandrup-Poulsen Diabetes and Suppressors of Cytokine Signaling Proteins Diabetes, February 1, 2007; 56(2): 541 - 548. [Full Text] [PDF] |
||||
![]() |
N. L. Dudek, H. E. Thomas, L. Mariana, R. M. Sutherland, J. Allison, E. Estella, E. Angstetra, J. A. Trapani, P. Santamaria, A. M. Lew, et al. Cytotoxic T-Cells From T-Cell Receptor Transgenic NOD8.3 Mice Destroy {beta}-Cells via the Perforin and Fas Pathways Diabetes, September 1, 2006; 55(9): 2412 - 2418. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D McKenzie, N. L Dudek, L. Mariana, M. M. Chong, J. A Trapani, T. W. Kay, and H. E Thomas Perforin and Fas induced by IFN{gamma} and TNF{alpha} mediate beta cell death by OT-I CTL Int. Immunol., June 1, 2006; 18(6): 837 - 846. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |